CWG
REGN icon

Cornerstone Wealth Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Cornerstone Wealth Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-291
Closed -$217K – 516
2026
Q1 		$217K Buy
291
+23
+9% +$17.6K 0.01% 416
2025
Q4 		$207K Buy
+268
New +$182K 0.01% 371
2025
Q2 		– Sell
-8,270
Closed -$5.24M – 330
2025
Q1 		$5.24M Buy
8,270
+4,405
+114% +$3.03M 0.43% 70
2024
Q4 		$2.75M Buy
3,865
+137
+4% +$115K 0.22% 101
2024
Q3 		$3.92M Buy
3,728
+10
+0.3% +$11.1K 0.32% 86
2024
Q2 		$3.91M Buy
3,718
+104
+3% +$101K 0.35% 77
2024
Q1 		$3.48M Sell
3,614
-1,457
-29% -$1.39M 0.32% 81
2023
Q4 		$4.45M Sell
5,071
-111
-2% -$91.4K 0.64% 46
2023
Q3 		$4.26M Sell
5,182
-87
-2% -$68.4K 0.76% 36
2023
Q2 		$3.79M Buy
5,269
+102
+2% +$78.6K 0.69% 57
2023
Q1 		$4.25M Sell
5,167
-61
-1% -$46K 0.76% 45
2022
Q4 		$3.77M Sell
5,228
-71
-1% -$52.4K 0.71% 47
2022
Q3 		$3.65M Buy
+5,299
New +$3.34M 0.81% 46
2021
Q4 		– Sell
-4,902
Closed -$2.97M – 164
2021
Q3 		$2.97M Buy
+4,902
New +$3.04M 0.52% 70

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cornerstone Wealth Group's REGN Position: Q2 2026 in Review

Cornerstone Wealth Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 291 shares — an estimated $217K sold.

Cornerstone Wealth Group first reported a position in REGN in Q3 2021 and held it in 14 quarters. The position peaked at $5.24M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cornerstone Wealth Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Cornerstone Wealth Group sold 291 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $217K.
  • Cornerstone Wealth Group first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 14 quarters.
  • Cornerstone Wealth Group's Regeneron Pharmaceuticals position peaked at $5.24M in Q1 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.